Subjective Complaints of Side Effects from Borderline Patients-2 Years after Day Clinic Treatment

被引:2
作者
Richter, Christoph [1 ,2 ]
机构
[1] Charite Univ Med Berlin, Klin Psychiat & Psychotherapie, Campus Mitte,Charitepl 1, DE-10117 Berlin, Germany
[2] Vivantes Klinikum Kaulsdorf, Klin Psychiat Psychotherapie & Psychosomat, Berlin, Germany
关键词
Borderline personality disorder; Dialectical behavioral therapy; Negative effects; Predictors; Psychotherapy research; Day clinic; DIALECTICAL BEHAVIOR-THERAPY; RANDOMIZED CONTROLLED-TRIALS; PERSONALITY-DISORDER; ADVERSE EVENTS; COST-EFFECTIVENESS; PSYCHOTHERAPY; INPATIENT; EFFICACY; SAFETY; DBT;
D O I
10.1159/000511619
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: The recording of negative effects (nE) of psychotherapy (PT) is important in order to identify weak points of PT and to improve the quality of treatment. The aim of the study is to find out which nE patients describe after day-clinic treatment for borderline personality disorders (BPD) with a dialectical behavioral therapy (DBT), which influencing factors are present, and how the content of the complaints is to be understood. Material and Methods: 22.6 months after the end of therapy, BPS patients were asked catamnestically which nE they remembered in relation to a 12-week day-clinic treatment. Measuring instruments were BDI, BSL-95, and INEP. Results: 35 women and 6 men answered (50% of 82). A mean of 11.2 nE was named, which was subjectively attributed to the DBT treatment. 97.6% report worsening of their condition, 87.8% recall problems in the therapeutic relationship, 43.9% report deterioration in their relationship, 70.7% report financial problems as a result of day-clinic treatment, and 29.3% about experience of stigmatization. The number of nE correlated with older age at the start of therapy (p < 0.01) and higher symptom burden based on the BSL-95 (p < 0.01) and BDI (p < 0.01) at the time of the survey. Discussion: It could be shown that when using the INEP, patients complain of considerable rates of negative experiences in the context of day-clinic treatment. The long recall period of 3 to 51 months and the correlation with the current symptoms call the validity of the answer into question. Results of self-rating instruments for recording side effects require very careful interpretation. (c) 2020 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:229 / 237
页数:9
相关论文
共 35 条
  • [21] Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria
    Li, Juan
    Chen, Wangqing
    Peng, Cong
    Zhu, Wu
    Liu, Zhaoqian
    Zhang, Wei
    Su, Juan
    Li, Jie
    Chen, Xiang
    PHARMACOGENOMICS JOURNAL, 2020, 20 (01) : 87 - 93
  • [22] Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia
    Mallhi, Tauqeer Hussain
    Khan, Yusra Habib
    Butt, Muhammad Hammad
    Salman, Muhammad
    Tanveer, Nida
    Alotaibi, Nasser Hadal
    Alzarea, Abdulaziz Ibrahim
    Alanazi, Abdullah Salah
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [23] Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer
    Ardin, Camille
    Humez, Sarah
    Leroy, Vincent
    Ampere, Alexandre
    Bordier, Soraya
    Escande, Fabienne
    Turlotte, Amelie
    Stoven, Luc
    Nunes, David
    Cortot, Alexis
    Gauvain, Clement
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [24] Side effects among healthcare workers from a large Milan universityhospital after second dose ofBNT162b2 mRNA COVID-19 vaccine
    Borroni, Elisa
    Consonni, Dario
    Cugno, Massimo
    Lombardi, Andrea
    Mangioni, Davide
    Bono, Patrizia
    Oggioni, Massimo
    Renteria, Sara Uceda
    Bordini, Lorenzo
    Nava, Carlo Domenico
    Letzgus, Matteo
    Silverj, Flaminia Gentiloni
    Castaldi, Silvana
    Rognoni, Magda
    D'Oro, Luca Cavallieri
    Carugno, Michele
    Riboldi, Luciano
    Ceriotti, Ferruccio
    Bandera, Alessandra
    Gori, Andrea
    Pesatori, Angela Cecilia
    MEDICINA DEL LAVORO, 2021, 112 (06): : 477 - 485
  • [25] The Effects of SARS-CoV-2 Pandemic Countermeasures on Patients Receiving Infiltrative Treatment for Musculoskeletal Disorders: a Study from an Italian Cohort
    Tarantino, D.
    Gnasso, R.
    Sirico, F.
    Corrado, B.
    MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL, 2021, 11 (04): : 673 - 677
  • [26] What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial
    Schennach, Rebecca
    Riedel, Michael
    Obermeier, Michael
    Jaeger, Markus
    Schmauss, Max
    Laux, Gerd
    Pfeiffer, Herbert
    Naber, Dieter
    Schmidt, Lutz G.
    Gaebel, Wolfgang
    Klosterkoetter, Joachim
    Heuser, Isabella
    Maier, Wolfgang
    Lemke, Matthias R.
    Ruether, Eckart
    Klingberg, Stefan
    Gastpar, Markus
    Seemueller, Florian
    Spellmann, Ilja
    Musil, Richard
    Moeller, Hans-Juergen
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (06) : 661 - 671
  • [27] Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer-BioNTech Vaccine in Children Aged 5-11 Years: An Italian Real-World Study
    Capponi, Martina
    Pulvirenti, Federica
    Cinicola, Bianca Laura
    Brindisi, Giulia
    Conti, Maria Giulia
    Colaiocco, Giovanni
    de Castro, Giovanna
    Guido, Cristiana Alessia
    Duse, Marzia
    Midulla, Fabio
    Zicari, Anna Maria
    Spalice, Alberto
    VACCINES, 2022, 10 (07)
  • [28] Erfolgreiche Behandlung in der Tagklinik — erlebte Veränderungen aus Sicht der PatientenEvaluierung der Arbeit der allgemeinen Tagklinik der Klinik für Psychiatrie und Psychotherapie der LMU MünchenSuccessful treatment in the day clinic of the Clinic for Psychiatry and Psychotherapy of LMU Munich. Experienced changes from the patients’ perspective
    Marie-Elena Neustädter
    Kristina Adorjan
    Nadja Kistner
    Mirjam Glaser
    Ira Hummel
    Sebastian von Saldern
    Ulrich Palm
    Sandra Dehning
    Oliver Pogarell
    Susanne Karch
    MMW - Fortschritte der Medizin, 2018, 160 (Suppl 5) : 6 - 10
  • [29] Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy
    Wang, Jun-Sing
    Lee, I-Te
    Lee, Wen-Jane
    Lin, Shi-Dou
    Su, Shih-Li
    Tu, Shih-Te
    Tseng, Yao-Hsien
    Lin, Shih-Yi
    Sheu, Wayne Huey-Herng
    JOURNAL OF DIABETES, 2017, 9 (03) : 248 - 255
  • [30] Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study
    Schernthaner, G.
    Rosas-Guzman, J.
    Dotta, F.
    Guerci, B.
    Simo, R.
    Festa, A.
    Kiljanski, J.
    Zhou, M.
    Gallwitz, B.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07) : 689 - 698